Cited by

• Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy.

  Busti F, Marchi G, Ugolini S, Castagna A, Girelli D. Busti F, et al. Pharmaceuticals (Basel). 2018 Sep 30;11(4):94. doi: 10.3390/ph11040094. Pharmaceuticals (Basel). 2018. PMID: 30274354 Free PMC article. Review.
• Inflammation and pancreatic cancer: An updated review.

  Shadhu K, Xi C. Shadhu K, et al. Saudi J Gastroenterol. 2019 Jan-Feb;25(1):3-13. doi: 10.4103/sjg.SJG_390_18. Saudi J Gastroenterol. 2019. PMID: 30588953 Free PMC article. Review.
• Elevated COX-2 Expression Promotes Angiogenesis Through EGFR/p38-MAPK/Sp1-Dependent Signalling in Pancreatic Cancer.

  Hu H, Han T, Zhuo M, Wu LL, Yuan C, Wu L, Lei W, Jiao F, Wang LW. Hu H, et al. Sci Rep. 2017 Mar 28;7(1):470. doi: 10.1038/s41598-017-00288-4. Sci Rep. 2017. PMID: 28352075 Free PMC article.
• Targeting Stress Erythropoiesis Pathways in Cancer.

  Vignjević Petrinović S, Jauković A, Milošević M, Bugarski D, Budeč M. Vignjević Petrinović S, et al. Front Physiol. 2022 May 25;13:844042. doi: 10.3389/fphys.2022.844042. eCollection 2022. Front Physiol. 2022. PMID: 35694408 Free PMC article. Review.
• Erythrocytosis in hepatocellular carcinoma portends poor prognosis by respiratory dysfunction secondary to mitochondrial DNA mutations.

  Ke S, Chen S, Dong Z, Hong CS, Zhang Q, Tang L, Yang P, Zhai J, Yan H, Shen F, Zhuang Z, Wen W, Wang H. Ke S, et al. Hepatology. 2017 Jan;65(1):134-151. doi: 10.1002/hep.28889. Epub 2016 Nov 25. Hepatology. 2017. PMID: 27774607 Free PMC article.